Searchable abstracts of presentations at key conferences in endocrinology

ea0029oc12.2 | Obesity Clinical | ICEECE2012

Lipid-induced insulin resistance is associated with a reduction of IGF1 bioactivity independent of changes in IGFBP-1 and -2 in humans

Arafat A. , Homssi S.v.G. , Weickert M. , Kraatz J. , Spranger J. , Frystyk J. , Pfeiffer A. , Mohlig M.

Objectives: Insulin interacts with the GH – insulin-like growth factor (IGF) system by a reciprocal regulation of IGF-binding proteins (IGFBPs) and GH, which in turn interact to regulate insulin sensitivity (IS). We previously showed that IGFBP-2 is involved in the insulin-induced reduction in IGF1 bioactivity. We here address the modulation of IGF1 bioactivity during acute lipid-induced insulin resistance.Methods: 18 healthy men (30.8±2.6 year...

ea0029p1001 | Growth hormone IGF axis - basic | ICEECE2012

Relationship between GH activity and reproductive hormones: a randomized cross-over study in healthy male volunteers treated with GH and a GH receptor antagonist for three weeks

Andreassen M. , Frystyk J. , Juul A. , Faber J. , Kristensen L.

Introduction: The GH/insulin-like growth factor 1 (IGF1) system may modulate the pituitary-gonadal axis in males. Direct pituitary and/or testicular effects might be involved, as well as indirect effects on sex hormone binding globulin (SHBG) and aromatase activity.Methods/design: Nine healthy male volunteers (mean age 37, range 29–49 years) were treated in random order with increasing doses of GH for three weeks (1st week 0.01, 2nd week 0.02, 3rd 0...

ea0026p242 | Pituitary | ECE2011

Relationship between GH activity and markers of inflammation: a cross-over study of healthy volunteers treated with GH and a GH antagonist for 3 weeks

Andreassen M , Frystyk J , Faber J , Kristensen L O

Introduction: Observations in patients with GH disturbances and in normal populations have suggested that GH/IGF1 activity could have anti-inflammatory effects. On the other hand, in vitro studies have shown that IGF1 may stimulate the immune system.Methods/design: The study population consisted of 12 healthy volunteers (mean age 36, range 27–49 years) treated with GH for 3 weeks (1st week 0.01 mg/day, 2nd 0.02 mg/day, 3rd 0.03 mg/day) and su...

ea0010p62 | Pituitary | SFE2005

Growth hormone and ghrelin responses to very intense exercise in humans

Stokes K , Sykes D , Gilbert K , Frystyk J

ObjectiveIt has been suggested that ghrelin may play a role in regulating the growth hormone (GH) response to exercise. This study was designed to determine whether very intense exercise alters circulating ghrelin concentrations. Design: Following Local Ethics Committee approval, 7 male volunteers were familiarised before completing two trials in a random order. In one trial participants performed a single 30-s sprint on a cycle ergometer, in the ...

ea0029p723 | Diabetes | ICEECE2012

A comparison of pharmacokinetics and pharmacodynamics of insulin aspart, biphasic insulin aspart 70, biphasic insulin aspart 50 and human insulin: a randomized, quadruple crossover study

Ma Z. , Parkner T. , Frystyk J. , Laursen T. , Lauritzen T. , Christiansen J.

Aims: To compare the pharmacokinetic and pharmacodynamic profiles of insulin aspart, biphasic insulin aspart 70 (BIAsp70), biphasic insulin aspart 50 (BIAsp50) and soluble human insulin under experimental conditions.Methods: In this randomised, four-period crossover study, 19 type 1 diabetic patients received subcutaneous injections of identical doses (0.2 U/kg) of either insulin aspart, BIAsp70, or BIAsp50 immediately before a standardized meal, or huma...

ea0026p569 | Cardiovascular endocrinology and lipid metabolism | ECE2011

α-Defensins are novel biomarkers of low grade inflammation with strong prognostic impact in patients with heart failure

Kistorp C , Christensen H M , Frystyk J , Flyvbjerg A , Hildebrandt P , Schou M , Faber J

Introduction: α-Defensins are recently described peptides, which are part of the innate immune system. Increased circulating levels are observed in conditions associated with chronic low grade inflammation, such as ischemic heart disease and in diabetes mellitus (DM). Recently we reported adverse prognostic implications of high α-defensins in patients with type 1 DM. However, it is not clear whether this finding may be generalized to include other groups such as pati...

ea0011p388 | Diabetes, metabolism and cardiovascular | ECE2006

Plasma N-terminal pro-brain natriuretic peptide and adiponectin levels increases during weight loss

Kistorp C , Bliddal H , Flyvbjerg A , Frystyk J , Hildebrandt P , Faber J

Objective: The cardiac hormone brain natriuretic peptide (BNP), including the N-terminal fragment of the prohormone (NT-proBNP) have in cross-sectional studies been demonstrated to be inversely associated with BMI. Clearance of these peptides by adipocyt specific receptors have been suggested. We therefore investigated the impact of weight loss on plasma levels of NT-proBNP and adiponectin in obese individuals.Methods: A total of 20 obese women and 2 men...